Novartis recall
This article was originally published in The Tan Sheet
Executive Summary
Novartis is voluntarily recalling five lots of GenTeal eye gel and two lots of GenTeal gel drops, the firm announces Nov. 16. The recall is a result of concerns regarding product sterility in both products. Novartis found the presence of mold in "a small number of samples" of the eye gel which may cause infection in susceptible people, particularly those with compromised immune systems, the company states. The sterility of the gel drops also was contested due to a risk of potential contamination. Consumers who may have purchased the products should contact Novartis, the company states...